We examined the in vivo role of membrane-bound prostaglandin E synthase (mPGES)-1, a terminal enzyme in the PGE 2 -biosynthetic pathway, using mPGES-1 knockout (KO) mice. Comparison of PGES activity in the membrane fraction of tissues from mPGES-1 KO and wild-type (WT) mice indicated that mPGES-1 accounted for the majority of lipopolysaccharide (LPS)-inducible PGES in WT mice. LPS-stimulated production of PGE 2 , but not other PGs, was impaired markedly in mPGES-1-null macrophages, although a low level of cyclooxygenase-2-dependent PGE 2 production still remained. Pain nociception, as assessed by the acetic acid writhing response, was reduced significantly in KO mice relative to WT mice. This phenotype was particularly evident when these mice were primed with LPS, where the stretching behavior and the peritoneal PGE 2 level of KO mice were far less than those of WT mice. Formation of inflammatory granulation tissue and attendant angiogenesis in the dorsum induced by subcutaneous implantation of a cotton thread were reduced significantly in KO mice compared with WT mice. Moreover, collagen antibody-induced arthritis, a model for human rheumatoid arthritis, was milder in KO mice than in WT mice. Collectively, our present results provide unequivocal evidence that mPGES-1 contributes to the formation of PGE 2 involved in pain hypersensitivity and inflammation.
Prostaglandin (PG)
1 E 2 is the most common prostanoid, being produced by a variety of cells and tissues, and has a broad range of biological activity. Recent advances in this research field have led to molecular identification and characterization of various enzymes involved in the biosynthesis of PGE 2 , including phospholipase A 2 (PLA 2 ), cyclooxygenase (COX) and terminal PGE synthase (PGES) (1) . Each of these three enzymatic steps can be rate limiting for PGE 2 biosynthesis and involves multiple enzymes/isozymes that can act in different phases of cell activation. The PGE 2 produced thus far is then released from the cells and acts on the four types of PGE receptor, EP1, EP2, EP3, and EP4, which are coupled with trimeric G protein signaling (2) .
PGES, which catalyzes the conversion of PGH 2 to PGE 2 , exists as membrane-associated and cytosolic enzymes. Two of them are membrane-bound enzymes and have been designated as mPGES-1 and mPGES-2 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . mPGES-1 is a glutathione (GSH)-requiring perinuclear protein belonging to the MAPEG (for membrane-associated proteins involved in eicosanoid and GSH metabolism) family (4 -6) . This enzyme is induced markedly by proinflammatory stimuli, is down-regulated by antiinflammatory glucocorticoids, and is functionally coupled with COX-2 in marked preference to COX-1. Induction of mPGES-1 expression has also been observed in various systems in which COX-2-derived PGE 2 has been implicated to play a critical role, such as inflammation, fever, pain, female reproduction, tissue repair, and cancer (4 -12) . Inducible expression of mPGES-1 is in part regulated by the mitogen-activated protein kinase pathways (13) , where the kinases may switch on the inducible transcription factor Egr-1 that in turn binds to the proximal GC box in the mPGES-1 promoter, leading to mPGES-1 transcription (14) . mPGES-2, which has a catalytic glutaredoxin-or thioredoxin-like domain and is activated by various thiol reagents, is synthesized as a Golgi membrane-associated protein, and the proteolytic removal of the N-terminal hydrophobic domain leads to the formation of a mature cytosolic enzyme (15, 16) . This enzyme is rather constitutively expressed in various cells and tissues and is functionally coupled with both COX-1 and COX-2 (16) . Cytosolic PGES (cPGES), a GSH-requiring enzyme constitutively expressed in a wide variety of cells, is functionally linked to COX-1, not COX-2, to promote immediate PGE 2 production (17) . This enzyme is regulated by formation of a complex with Hsp90, a molecular chaperone (18) . In addition, two cytosolic GSH-S-transferases (2 and 3) have the ability to catalyze the isomerization of PGH 2 to PGE 2 , at least in vitro (19) .
The importance of PGE 2 in various pathophysiological events dictates the necessity to understand the role of each PGES enzyme in vivo. In fact, biochemical and cell biological analyses have led to the proposal that among the PGES enzymes identified so far, mPGES-1 may be most critically responsible for the production of the PGE 2 implicated in various pathophysiological events. An initial study with mPGES-1 knock-out (KO) mice has reported the essential role of mPGES-1 in lipopolysaccharide (LPS)-stimulated delayed PGE 2 production by macrophages, although these mice are fertile, develop normally after birth, and retain LPSstimulated production of various cytokines (20) . In this study, we used mPGES-1 KO mice to analyze the role of mPGES-1 in inflammation-associated pain hypersensitivity, tissue granulation accompanying angiogenesis, and arthritis induced by collagen antibody.
EXPERIMENTAL PROCEDURES
Animals-Male C57BL/6 mice were obtained from Saitama Animal Center. The mPGES-1 KO mice and littermate wild-type (WT) mice (C57BL/6 ϫ 129/SvJ background) were described previously (20) . Male mice (7 weeks old) were used in each experiment. Mice were housed in microisolator cages in a pathogen-free barrier facility, and all experiments were performed under approved institutional guidance.
Agents-LPS (Escherichia coli 0111:B4), goat anti-mouse vascular endothelial cell growth factor (VEGF), and indomethacin were purchased from Sigma. Mouse anti-human cPLA 2 ␣ monoclonal antibody and goat anti-human COX-1 and COX-2 polyclonal antibodies were purchased from Santa Cruz Biotechnology. Rabbit antibodies against human mPGES-1 (12), mPGES-2 (16) , and cPGES (17) were prepared as described previously. Rabbit anti-mouse histidine decarboxylase (HDC) antibody was donated by Dr. S. Tanaka (Kyoto University) (21) . Enzyme immunoassay kits for PGE 2 , 6-keto-PGF 1␣ (a stable end product of PGI 2 ), PGF 2␣ , and thromboxane B 2 (a stable end product of thromboxane A 2 ) and the COX-2 inhibitor NS-398 were purchased from Cayman Chemicals. The COX-1 inhibitor valeryl salicylate was a generous gift from Dr. W. Smith (University of Michigan). Oligonucleotides were purchased from Bex.
Measurement of PGES Activity-PGES activity was measured by assessment of conversion of PGH 2 to PGE 2 as reported previously (4). Briefly, cell or tissue homogenates were centrifuged at 100,000 ϫ g for 1 h at 4°C, and the membrane fractions were used as an enzyme source. An aliquot (10 g of protein equivalents) was incubated with 0.5 g of PGH 2 for 30 s at 24°C in 0.1 ml of 0.1 M Tris-HCl (pH 8.0) containing 1 mM glutathione and 5 g of indomethacin. After stopping the reaction by the addition of 100 mM FeCl 2 , the PGE 2 content of the reaction mixture was quantified by use of the enzyme immunoassay kit.
Preparation and Activation of Peritoneal Macrophages-Peritoneal cells were recovered from mice that had received thioglycollate medium (Difco) (1 ml/20 g of body weight) 4 days before (22) . The peritoneal cells were seeded into 6-or 12-well plates (Iwaki Glass) at a cell density of 10 6 cells/ml in 2 ml (for 6-well plates) or 1 ml (for 12-well plates) of RPMI medium (Nissui) supplemented with 10% (v/v) fetal calf serum. After incubation for 2 h in a CO 2 incubator, the supernatants and nonadherent cells were removed. More than 90% of adherent cells were macrophages. Then the cells were incubated with or without 10 g/ml LPS in medium containing 2% serum for appropriate periods. The supernatants were taken for enzyme immunoassay for prostanoids, and the cells were subjected to Western blotting (see below).
Experiments with mPGES-1 Small Interfering RNA (siRNA)-Two synthetic hairpin-forming oligonucleotides directed at mPGES-1, 5Ј-G-ATCCCGGCCTTTGCCAACCCCGAGTTCAAGAGACTCGGGGTTGG-CAAAGGCCTTTTTTGGAAA-3Ј (sense) and 3Ј-AGCTTTTCCAAAAAA-GGCCTTTGCCAACCCCGAGTCTCTTGAACTCGGGGTTGGCAAAG-GCCGG-5Ј (antisense), both of which harbored BamHI and HindIII sites at their 5Ј-and 3Ј-ends, respectively, were annealed, cut with BamHI and XbaI, and then ligated into the BamHI/XbaI-digested pRNA-U6.1/Hygro vector (GenScript) using T4 ligase (Takara Biomedicals). After transformation into DH5␣-competent cells (TOYOBO), the plasmid was extracted and purified using the Endofree Plasmid Maxi Kit (Qiagen).
Transfection of the plasmid into peritoneal macrophages was performed by lipofection, as described previously (4) . Briefly, 5 g of the plasmid was mixed with 10 l of LipofectAMINE 2000 (Invitrogen) in 100 l of Opti-MEM (Invitrogen) for 30 min and then added to macrophages in 0.5 ml of Opti-MEM in 12-well plates. After incubation for 24 h, the medium was replaced with 1 ml of fresh culture medium and then incubated with or without 10 g/ml LPS in medium containing 2% fetal calf serum for 16 h.
Acetic Acid Writhing Reaction-The writhing reaction was induced in mice by intraperitoneal injection of 0.9% (v/v) acetic acid solution at a dose of 5 ml/kg, as described previously (23, 24) . In one group of animals, LPS (10 g/0.1 ml of saline/mouse) was given intraperitoneally 18 h before the injection of acetic acid solution. A suspension of 1 mg/ml indomethacin in 1% (w/v) sodium carboxymethylcellulose solution was injected subcutaneously into mice (at final dose of 10 mg/kg indomethacin/mouse) 30 min before the injection of acetic acid solution. The number of writhing responses was counted every 5 min.
For measurement of prostanoids, mice were sacrificed 15 min after acetic acid injection, and their peritoneal cavities were washed twice with Hanks' balanced salt solution (Nissui) containing 10 M indomethacin. The pooled peritoneal fluids were adjusted to pH 3.0 with 1 N HCl and passed through Sep-Pak C18 cartridges (Waters), and the retained PGs were eluted from the cartridges with 8 ml of methanol, as described previously (23, 24) . A trace amount of [ 3 H]PGE 2 (Cayman Chemicals) was added to the samples before passage through the cartridges to calibrate the recovery of PGs. The solvent of the samples was evaporated, and then PGs were dissolved in an aliquot of buffer and assayed with commercial enzyme immunoassay kits for each PG.
Cotton Thread-induced Granulation Tissue Formation-Cotton threads (Araiwa Co.) were washed overnight with ethyl acetate and dried at room temperature before being cut into 1-cm lengths (3 mg weight), and sterilized by dry heat at 180°C for 2 h. The cotton threads were implanted subcutaneously into the dorsum of anesthetized mice by using a 13-gauge implant needle (Natume), as described previously (25) . After appropriate periods, the mice were anesthetized and killed, and the granulation tissues were dissected together with the cotton threads and weighed. As required for the experiments, indomethacin (5 mg/kg) or vehicle was injected intraperitoneally every day. The isolated granulation tissues were washed, cut into small pieces with scissors, and homogenized with a Polytron homogenizer in a homogenizing buffer comprising 20 mM Tris-HCl (pH 7.4), 250 mM sucrose, 0.5 mM EDTA, 10 M indomethacin, 1 M phenylmethylsulfonyl fluoride, and 0.5% (v/v) Triton X-100. The obtained tissue homogenates were centrifuged at 3,000 rpm for 5 min, and 200-l aliquots of the supernatants were centrifuged again at 14,000 ϫ g for 30 min at 4°C. Then, the hemoglobin concentrations in the supernatants were determined spectrophotometrically by measuring the absorbance at 540 nm with a hemoglobin assay kit (Wako). PGs were extracted from the homogenates with Sep-Pak C18 cartridges and quantified by enzyme immunoassay, as described above.
Western Blotting-Aliquots of samples (20-g protein equivalents) were subjected to SDS-PAGE using 7.5% (for cPLA 2 ␣ and COXs) or 12.5% (for PGESs) gels under reducing conditions. The separated proteins were electroblotted onto nitrocellulose membranes (Schleicher & Schuell) with a semidry blotter (MilliBlot-SDE system; Millipore). After blocking with 3% (w/v) skim milk in Tris-buffered saline (TBS (pH 7.4)) containing 0.05% Tween 20 (TBS-Tween), the membranes were probed with the respective antibodies (1:5,000 dilution for cPLA 2 ␣, COX-2, and PGESs; 1:1,000 dilution for VEGF; 1:2,500 dilution for HDC, and 1:20,000 dilution for COX-1 in TBS-Tween) for 2 h, followed by incubation with horseradish peroxidase-conjugated anti-mouse (for cPLA 2 ␣), anti-rabbit (for PGESs and HDC), or anti-goat (for COXs and VEGF) IgG antibody (1:5,000 dilution in TBS-Tween) for 2 h, and were visualized with the ECL Western blot system (PerkinElmer Life Sciences), as described previously (4) .
Immunohistochemistry-Formalin-fixed, paraffin-embedded sections of the granulation tissue sections were incubated with Target Retrieval Solution (DAKO) as required, incubated for 10 min with 3% (v/v) H 2 O 2 , washed three times with TBS for 5 min each, incubated for 30 min with 5% (v/v) skim milk, washed three times with TBS-Tween for 5 min each, and incubated for 2 h with anti-mPGES-1 antibody in TBS (1:100 dilution). After five washes, the sections were treated with the CSA system staining kit (DAKO) followed by counterstaining with hematoxylin and eosin, as described previously (12) .
Arthritis Model-Arthritis was induced in mPGES-1 KO and WT mice by the modified method of Terato et al. (26, 27) . Briefly, mice were injected intraperitoneally with 10 mg of anti-type II collagen monoclonal antibodies (Immuno-Biological Laboratory) on day 0. On days 2 and 7, 50 g of LPS (100 l of 500 g/ml solution in saline) was injected intraperitoneally followed by an intermittent LPS injection every 3 days to the end of the experiments. As a control, 2.5 or 0.1 ml of saline was injected in place of the antibodies or LPS, respectively. The clinical severity of arthritis was graded on a 0 -3 scale as follows: 0, normal; 1, swelling of ankle or wrist, or limited to digits; 2, swelling of the entire paw; 3, maximal swelling. Each limb was graded by a single blinded observer, allowing a maximum arthritis score of 12 for each animal. On day 28, the mice were anesthetized with ketamine/xylazine solution and a radiograph was taken with a soft x-ray apparatus (CMB-2; SOFTEX). After perfusion of mice with 4% (w/v) buffered paraformaldehyde, fore and right hind limbs were removed, decalcified in 10% (w/v) EDTA, and embedded in paraffin, and 5-m sections were stained with hematoxylin and eosin or toluidine blue. Bone resorption was evaluated by the tartrate-resistant acid phosphatase (TRAP) staining of the carpometacarpal joints. TRAP-positive cells were stained at pH 5.0 in the presence of L(ϩ)-tartaric acid using naphthol AS-MX phosphate (Sigma) in N,N-dimethylformamide as the substrate. The specimens were subjected to histomorphometric analyses using a semiautomated system (Osteoplan II; Carl Zeiss), and measurements were made at a magnification of ϫ400. Osteoclast number and eroded surface were measured at the carpometacarpal joints in the metacarpal bones.
After perfusion fixation, left femora and tibiae were excised and bone mineral density (BMD) was measured by dual energy x-ray absorptiometry using a bone mineral analyzer (DCS-600; Aloka Co.). To evaluate bone destruction of the knee joint area, BMDs of four equal longitudinal divisions in femur and tibia were measured, and the BMD around the knee joint was expressed by the sum of those in the distal one-fourth of femur and in the proximal one-fourth of tibia (28) .
On day 6, all four paws including wrist or ankle joints were collected and homogenized in a homogenizing buffer. Then, aliquots were taken for PGE 2 enzyme immunoassay and Western blotting, as described above.
Other Methods-Protein concentrations were determined by a bicinchoninic acid protein assay kit (Pierce) with bovine serum albumin (Sigma) as a standard. Data were analyzed by Student's t test. Results are expressed as the mean Ϯ S.E., with p ϭ 0.05 as the limit of significance. Fig. 1A illustrates PGES enzymatic activities in the membrane fraction of various tissues from mPGES-1 KO and WT mice with or without 24-h treatment with LPS. Basal PGES activities (i.e. without LPS administration) in the brain, heart, intestine, and ear were similar between WT and KO mice, whereas the activity in the kidney of WT mice was about 4-fold higher than that of KO mice (Fig. 1A) . Treatment of WT mice with LPS resulted in 3-8-fold increases in PGES activity over the basal levels of the individual tissues. In tissues of mPGES-1 KO mice, LPS-stimulated increases in PGES activity over the basal levels were only modest, although Ͻ2-fold increases were consistently observed in all tissues examined (Fig. 1A) .
RESULTS

mPGES-1 Is a Major Inducible PGES in Vivo-
Immunoblotting of the membrane fractions of individual tissues revealed that the expression of mPGES-1 was markedly induced in tissues of WT mice, whereas no mPGES-1 protein was detected in tissues of KO mice (Fig. 1B) . Constitutive expression of mPGES-1 was seen only in the kidney of WT mice (Fig. 1B) , in agreement with a recent immunohistochemical study demonstrating the expression of mPGES-1 in the epithelia of distal tubules and medullary collecting ducts in this organ (29) . In the brain (Fig. 1B) , heart, and ear (data not shown), LPS-induced COX-2 expression in KO mice was similar to that in WT mice. In the intestine and kidney, COX-2 expression in LPS-treated KO mice was significantly lower than that in replicate WT mice (Fig. 1B) , suggesting that mPGES-1-derived PGE 2 amplifies COX-2 induction in these tissues. Thus, mPGES-1 represents a major inducible membrane-associated PGES in various tissues of LPStreated mice. However, the fact that substantial levels of PGES activity still exist in tissues of KO mice implies the presence of another membrane-bound PGES that is expressed rather constitutively.
Evaluation of the Role of mPGES-1 in PGE 2 Production by LPS-stimulated Macrophages-Accumulating evidence suggests that delayed PGE 2 production by LPS-stimulated macrophages depends on inducible COX-2 and mPGES-1 (4, 20, 22) . To reevaluate the contribution of mPGES-1 to this event, we first took advantage of siRNA technology. As shown in Fig. 2A , ex vivo stimulation of C57BL/6 mouse-derived thioglycollate-induced peritoneal macrophages with LPS led to a marked increase in PGE 2 production, which was accompanied by de novo induction of COX-2 and mPGES-1. This PGE 2 -biosynthetic response was reduced dramatically in replicate cells transfected with mPGES-1 siRNA, in which mPGES-1 expression was greatly decreased without reduction of COX-2 expression ( Fig. 2A) . This indicates that mPGES-1 contributes to the production of the majority of PGE 2 in LPS-stimulated macrophages.
Consistent with this observation, LPS-stimulated PGE 2 production was impaired markedly in macrophages derived from mPGES-1 KO mice relative to those derived from WT mice over the entire culture period (Fig. 2B ). Constitutive expression of cPLA 2 ␣, COX-1, cPGES, and mPGES-2 (appearing as a doublet, reflecting the processed and unprocessed forms (16)) and inducible expression of COX-2 were similar between WT-and KO-derived macrophages (Fig. 2C) , indicating that mPGES-1 deficiency does not affect the expression of other enzymes implicated in PGE 2 synthesis in these cells. The levels of other prostanoids, including PGF 2␣ , thromboxane A 2 , and particularly PGI 2 , produced by mPGES-1 KO cells were modestly higher than those produced by WT cells (Fig. 2D) , which may reflect a shunting effect because of the defect of the metabolic flow from PGH 2 to PGE 2 .
It should be noted, however, that a small but significant production of PGE 2 was still observed in mPGES-1-deficient macrophages (Fig. 2B) . The level of PGE 2 released by mPGES-1-null macrophages reached as much as 8% of that produced by WT cells after 12-h culture with LPS (Fig. 2B, inset) . To assess which COX isoforms contribute to PGE 2 production in mPGES-1-deficient macrophages, the effects of specific inhibitors of COX-1 (valeryl salicylate) and COX-2 (NS-398) on PGE 2 generation were examined. As shown in Fig. 2E , PGE 2 production was reduced markedly by NS-398, whereas valeryl salicylate was without effect in both WT and KO cells. This result indicates that the small production of PGE 2 observed in mPGES-1-null macrophages still depends largely on COX-2. Because mPGES-2 and cPGES were expressed in these cells (Fig. 2C) , this small PGE 2 production might occur through these enzymes.
During the course of this study, we noted that the number of macrophages recovered from the peritoneal cavity 4 days after the injection of thioglycollate was significantly lower in mPGES-1 KO mice than in WT mice (Fig. 2F ). This result suggests that mPGES-1-derived PGE 2 may participate in the migration of macrophages into inflamed sites, an event also found in the model of inflammatory granulation tissue formation (see below).
Participation of mPGES-1 in Pain Nociception-During the inflammatory reaction, pain is produced through complex interactions between various inflammatory mediators, one of which is PGE 2 . Studies using COX inhibitors as well as PG receptor-deficient mice have established the important role of PGE 2 as well as PGI 2 in pain nociception (24, 30 -32) . We therefore used the acetic acid writhing test to evaluate the contribution of mPGES-1 to the production of PGE 2 involved in nociceptive pain perception. We were particularly interested in inflammatory pain hypersensitivity in LPS-pretreated animals because the expression levels of both COX-2 and mPGES-1 are markedly elevated after LPS treatment ( Figs. 1 and 2 ). Injection of acetic acid into the peritoneum of WT mice induced stretching behavior, which peaked at 5-10 min and then declined gradually over 30 min (Fig. 3A, upper panel) . This basal writhing response was augmented significantly at all time points if LPS had been injected into mice 24 h before acetic acid injection (Fig. 3A, lower panel) . Notably, the LPS-primed, acetate-induced pain response was reduced markedly in mPGES-1 KO mice compared with that in replicate WT mice over the entire experimental period (Fig. 3B, lower panel) . Under LPS-unprimed (basal) conditions, the writhing response of mPGES-1 KO mice was also significantly less than that of WT mice (Fig. 3B, upper panel) , although the difference between WT and KO mice was less obvious than that observed after LPS priming. Thus, the total numbers of stretching of mPGES-1 KO mice over the initial 15 min after acetic acid administration were reduced by ϳ45 and ϳ80% relative to those of WT mice under basal and LPS-primed conditions, respectively (Table I) . Both the basal and LPS-primed writhing responses of WT mice were reduced by 70 -80% by treatment with indomethacin (Fig. 3C) . These results collectively suggest that mPGES-1-derived PGE 2 is a main mediator of LPS-primed pain hypersensitivity, whereas the basal pain response may also involve PGE 2 produced by other PGES(s) or other additional prostanoid(s) such as PGI 2 , because this pain response is reduced markedly in mice lacking the PGI receptor IP (24, 30).
FIG. 2. mPGES-1 is an essential component for PGE 2 production by LPS-stimulated macrophages.
A, peritoneal macrophages derived from C57BL/6 mice were transfected with mPGES-1 siRNA or mock control and then treated for 24 h with (ϩ) or without (Ϫ) LPS. PGE 2 released into the supernatants was quantified. Cells were subjected to Western blotting for COX-2 and mPGES-1 (bottom). B, peritoneal macrophages obtained from WT and mPGES-1 KO mice were incubated for the indicated periods with or without LPS to assess PGE 2 release. PGE 2 production by KO macrophages is magnified in the inset. C, Western blotting of the PGE 2 biosynthetic enzymes in WT-and KO-derived macrophages after 24-h culture with (ϩ) or without (Ϫ) LPS. D, production of other PGs by WT and KO macrophages after 24-h culture with (ϩ) or without (Ϫ) LPS. E, effects of COX isozyme-selective inhibitors on LPS-stimulated PGE 2 production by WT and KO macrophages. In WT mice, the level of PGE 2 in the peritoneal cavity 15 min after acetic acid injection was about 6-fold higher in the LPSprimed group than in the LPS-unprimed group (Fig. 3D ), in agreement with the elevated expression of COX-2 and mPGES-1 in response to LPS (see Figs. 1 and 2 ). In mPGES-1 KO mice, peritoneal PGE 2 levels were reduced only by ϳ15% (this difference was statistically insignificant) and by as much as ϳ70% compared with those in WT mice under the basal and LPS-primed conditions, respectively (Fig. 3D) . Given that the reduction of the peritoneal PGE 2 level is less marked than that of the writhing response in KO mice, particularly under LPSunprimed condition, we speculate that PGE 2 produced in the spinal cord and dorsal root ganglia, in which a trace level of mPGES-1 is constitutively expressed (33) , might also affect pain perception by spinal neurons. As reported previously (23, 24) , PGI 2 is the major prostanoid released into the peritoneal cavities of mice during the acetic acid writhing response with or without LPS priming (Fig. 3D) . Consistent with the elevation of COX-2 expression after LPS treatment, the peritoneal PGI 2 level was 1.8-fold higher in LPS-treated than in untreated WT mice (Fig. 3D) . Interestingly, the levels of PGI 2 in mPGES-1 KO mice were significantly lower than in WT mice after LPS priming (Fig. 3D) , suggesting partial dependence of PGI 2 synthesis on mPGES-1-derived PGE 2 in this setting. Production of PGF 2␣ was increased 3-fold after LPS priming and was unaffected by mPGES-1 deficiency in both basal and LPS-primed situations (Fig. 3D) . The greater -fold increase in PGF 2␣ than in PGI 2 after LPS treatment may reflect distinct functional coupling between COX-2 and various terminal synthases (34) or LPS-mediated induction of PGF 2␣ synthase (35) . Indomethacin treatment of WT mice reduced the peritoneal PGI 2 levels by Ͼ90% with or without LPS priming (data not shown), indicating that the reduced writhing response by indomethacin (Fig.  3C ) is related to almost complete inhibition of COX enzymes.
Participation of mPGES-1 in Inflammatory Granulation and Angiogenesis-Subcutaneous implantation of a cotton thread in the dorsum of mice induces formation of granulation tissue with angiogenesis (25) . As shown in Fig. 4A , granulation tissue formation and angiogenesis around the implanted cotton thread were obvious in C57BL/6 mice, events that were ameliorated in replicate mice treated with indomethacin, implying the involvement of prostanoid(s). Quantification studies revealed that the weights of and the levels of hemoglobin (an indicator of angiogenesis) and PGE 2 in the granulation tissue were reduced significantly in indomethacin-treated mice compared with vehicle-treated mice (Fig. 4B) .
To evaluate the contribution of mPGES-1 to this inflammatory process, cotton threads were implanted into the dorsum tissues of mPGES-1 WT and KO mice. As in the case of C57BL/6 mice, progressive formation of granulation tissue and vascular networks in the subcutaneous tissues around the implanted cotton thread was visually obvious in WT mice, and this process peaked on day 5 (Fig. 4C) . In comparison, formation of granulation tissue and blood vessels appeared mild in mPGES-1-deficient mice (Fig. 4C) . Accordingly, there was a significant increase in the wet weight of the cotton threadassociated granulation tissue in WT mice over days 5-7, whereas this increase was not observed appreciably in mPGES-1 KO mice (Fig. 4D, left panel) . Angiogenesis, as quantified by hemoglobin levels, in the granulation tissue peaked on days 3-5 in WT mice and then declined, and there was ϳ50% reduction in hemoglobin levels in KO mice relative to WT mice (Fig. 4D, middle panel) . PGE 2 levels in the granulation tissue of WT mice peaked on days 1-3 and then declined (Fig. 4D,  right panel) . Thus, it appears that increased PGE 2 production kinetically precedes angiogenesis, followed by granulation tissue formation in WT mice. In mPGES-1 KO mice, PGE 2 levels were almost constant throughout the experimental period, and there was no increase in PGE 2 during days 1-3 (Fig. 4D, right  panel) . On day 7, the hemoglobin and PGE 2 levels in the granulation tissue of WT mice returned to levels comparable with those of KO mice (Fig. 4D) .
As assessed by immunoblotting, COX-2 and mPGES-1 were not expressed in the normal dorsum of WT mice (data not shown) and were markedly induced in the granulation tissue formed after cotton thread implantation (Fig. 4E) . The inducible expression of COX-2 reached a peak on days 1-3 and then declined (Fig. 4E) , thus roughly coinciding with the levels of PGE 2 in the granulation tissue (Fig. 4D, right panel) . The expression level of COX-2 was slightly higher in WT mice than in KO mice on day 3. The expression of mPGES-1 reached a plateau peak on days 3-5 in WT mice, whereas mPGES-1 was absent from KO mice over the whole period (Fig. 4E) . Expression of COX-1 and mPGES-2 was unchanged over the experimental period and was similar between WT and KO mice (Fig. 4F) .
Granulation tissue formation and angiogenesis observed in this model depend on the up-regulation of VEGF, an essential angiogenic factor, and HDC, an enzyme required for the synthesis of histamine (25) . We therefore assessed by immunoblotting the expression of VEGF and HDC in the granulation tissue of mPGES-1 KO and WT mice. Although the expression levels of VEGF were similar between WT and KO mice on day 1, there were significant elevations in VEGF expression in WT mice compared with KO mice on days 3-5 (Fig. 4E) . The expression levels of HDC, which appeared as 70-and 55-kDa forms, were significantly higher in WT mice than in KO mice over the whole experimental periods (Fig. 4E) . These results suggest that mPGES-1-derived PGE 2 plays an augmentative role in the expression of VEGF and HDC.
Histological analyses of the granulation tissues revealed the presence of a fibroblastic layer around the implanted cotton thread, which was thicker in WT mice than in mPGES-1 KO mice (Fig. 5, A and B) . The smooth muscle layer in WT mice was edematous, an event that was less clear in KO mice (Fig.  5A ). In addition, more capillary vessels were found in the fibroblastic layer of WT mice than in that of KO mice (Fig. 5B) . For quantification of capillary vessel formation, we took seven digital images of randomly selected areas of the granulation tissue of WT and KO mice, and the numbers of capillary vessels and the pixels of vessel areas (as an indication of vessel volumes) were evaluated. As a result, the numbers of capillary vessels of WT and KO mice/digital image were 23.3 Ϯ 4.7 and 11.7 Ϯ 1.4 (p Ͻ 0.05), respectively, and the pixel numbers were 9,800 Ϯ 1,500 and 4,200 Ϯ 750 (p Ͻ 0.05), respectively, thus revealing ϳ50% reduction in capillary vessel formation (in terms of both numbers and sizes) in KO mice compared with WT mice. Immunohistochemical staining of these tissues with anti-mPGES-1 antibody showed that mPGES-1 immunoreactivity was distributed mainly in macrophages infiltrating into the fibroblast layer of WT mice (Fig. 5, C and D) . Fewer macrophages were found in replicate KO mice, from which mPGES-1 immunoreactivity was absent.
Participation of mPGES-1 in Inflammatory Arthritis-Experimental and clinical evidence suggests that PGE 2 is a critical mediator of rheumatoid arthritis in humans and in related animal models (36 -42) . Therefore, we next examined the contribution of mPGES-1 to collagen antibody-induced arthritis (CAIA), an experimental animal model for human rheumatoid arthritis. Compared with classical collagen-induced arthritis (CIA), the induction of which is limited to only a few strains such as DBA/1 (43), the CAIA model has the great advantages of applicability to various strains, rapid induction, and high incidence of arthritis. To this end, a mixture of anti-type II collagen monoclonal antibodies was administered to mPGES-1 KO and WT mice with C57BL/6 ϫ 129/SvJ background. However, after application of the antibody mixture plus only one injection of LPS (on day 2), active inflammation declined after 2 weeks so that we were unable to observe obvious bone destruction radiographically (data not shown). We therefore performed booster injections of LPS into these mice every 3 days from day 7, which eventually allowed sustained arthritic inflammation over 4 weeks.
The arthritis score in WT mice began to rise on day 4, reaching a peak value (score ϳ7) on days 7-10, and then decreased gradually to a still elevated score of Ͼ5 by 4 weeks (Fig. 6A) . Although replicate mPGES-1 KO mice also developed arthritic symptoms during the same period, there was a significant reduction in the severity of the disease in mPGES-1 KO mice compared with WT mice (40ϳ50% reduction from days 7 to 28). In contrast to the reduced severity, however, the incidence of arthritis was 100% in both WT and KO mice. On day 6, when the arthritis was developing (Fig. 6A) , PGE 2 levels in all four paws of arthritis-induced WT and KO mice were increased significantly over those in their respective saline control groups (Fig. 6B) . Importantly, there was a ϳ50% reduction in the PGE 2 level in arthritis-induced KO mice relative to that in replicate WT mice (Fig. 6B) . As assessed by immunoblotting, the expression of COX-2 and mPGES-1 was increased markedly, whereas that of mPGES-2 and cPGES remained unchanged, in arthritis-induced WT mice (Fig. 6C) . In mPGES-1 KO mice, the inducible expression of COX-2 and constitutive expression of cPGES and mPGES-2 were similar to those in WT mice, whereas mPGES-1 was absent.
Histopathological examination using knee joint sections of arthritis-induced mice on day 28 revealed notable joint destruction in WT mice (Fig. 7A, upper two panels) . Cartilage degeneration was also evident in the toluidine blue-stained sections (Fig. 7A, lower two panels) , which is suggestive of significant proteoglycan loss in articular cartilage of WT mice. In contrast, these histopathological changes were rather mild in arthritisinduced KO mice (Fig. 7A, right panels) . We further compared the arthritis-induced bone loss between the two genotypes by measuring BMD of the periarticular region. The decrease in BMD of diseased WT mice relative to control WT mice was nearly 20%, whereas that of KO mice was only 12%, thereby revealing about 40% less BMD loss in KO mice than in WT mice (Fig. 7B) . Fig. 7C shows radiographs of forepaws and histologies of the TRAP staining of the metacarpal bones in arthritis-induced WT and KO mice on day 28. Bone erosion and periositis were obvious in WT mice but were not clear in KO mice. Furthermore, histomorphometric parameters of bone resorption, namely osteoclast number and percent eroded surface, were much more increased by arthritis in WT mice than in KO mice (Fig. 7D) . Collectively, these results indicate that mPGES-1-derived PGE 2 may be involved in development of CAIA and the accompanying joint destruction.
DISCUSSION
In keeping with various pathophysiological roles of PGE 2 , as demonstrated by pharmacological inhibition and gene targeting of COX-2 and the four PGE receptors EP1-EP4 (1, 2), we used mPGES-1-deficient mice (20) to evaluate the in vivo functions of mPGES-1, a terminal PGE 2 -biosynthetic enzyme that is markedly up-regulated during inflammatory responses (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . We provide unequivocal evidence that mPGES-1 plays a pivotal role in the production of PGE 2 linked to inflammatory pain hypersensitivity, inflammatory granulation associated with angiogenesis, and inflammatory arthritis accompanying bone destruction. Even though significant PGES enzymatic activity, which may be ascribed to mPGES-2, cPGES, or possibly other as yet unidentified enzymes, still exists in various tissues and cells of mPGES-1 KO mice, mPGES-1 accounts for the majority of the inducible PGES activity (Fig. 1) , and importantly, it contributes far more critically to the propagation of inflammatory responses. This conclusion is supported by the facts that mPGES-1 exhibits the highest catalytic activity among the PGES enzymes identified so far (11) and that this enzyme shows preferential, if not strict, coupling selectivity with COX-2, an inducible COX isoform that has been implicated in various inflammatory disorders (4). Our results are in many aspects consistent with a recent report by Audoly and co-workers (44) , who also demonstrated reduced pain nociception and inflammatory arthritis in their mPGES-1 KO mice, although there are some subtle differences in the evaluations of the results.
No doubt, PGE 2 is a critical modifier of pain nociception (24, 30, 31) . It has been reported that in mice with a mixed genetic background of C57BL/6 ϫ 129/SvJ, the PGI receptor IP mainly mediates immediate pain (30) , whereas the PGE receptor EP3, in cooperation with IP, participates in pain hyperalgesia after priming with LPS (24), in the acetic acid-induced writhing model. On the other hand, another study using EP1-deficient mice of the DBA/1 background has demonstrated the striking FIG. 6 . Reduced severity of CAIA in mPGES-1 KO mice. mPGES-1 KO and WT mice were injected with anti-collagen monoclonal antibodies (mAb) on day 0 and boosted with LPS on days 2 and 7, followed by intermittent LPS injections every 3 days. A, the clinical arthritis score was graded on a 0 -3 scale as described under "Experimental Procedures." Values are the mean Ϯ S.E. (n ϭ 10 -11; *, p Ͻ 0.05 versus monoclonal antibody/LPStreated WT mice on each day). B and C, all four paws of mice in each group were removed on day 6, and homogenized tissues were subjected to PGE 2 measurement (B) and Western blotting (C). In B, values are the mean Ϯ S.E. (n ϭ 3; *, p Ͻ 0.05 versus replicate WT mice).
contribution of this PGE receptor subtype to acute pain nociception in the same model (31) . By means of the acetic acid stretching test with or without LPS priming, we have shown that mPGES-1 contributes more profoundly to LPS-primed inflammatory hyperalgesia than to basal acute pain perception (Fig. 3) . Thus, ϳ80% suppression of the pain response and of peritoneal PGE 2 levels was observed in LPS-pretreated mPGES-1-null mice compared with replicate WT mice, which is consistent with elevated expression of COX-2 and mPGES-1 in response to LPS.
Previous studies employing COX isozyme-selective inhibitors or KO mice have indicated that COX-1, not COX-2, mainly mediates the basal acetic acid writhing reaction (32) . Here we observed ϳ45% reduction of the basal writhing reaction in mPGES-1 KO mice relative to replicate WT mice (Fig. 3) , implying a significant (even if less pronounced) contribution of preexisting mPGES-1 to COX-1-dependent acute pain. Indeed, COX-1/mPGES-1 coupling can occur in the immediate response if sufficient levels of arachidonic acid are supplied (4). However, the peritoneal PGE 2 level in KO mice was only slightly lower (statistically insignificant) than that in WT mice under the basal condition (Fig. 3D) , suggesting that the PGE 2 produced by mPGES-1 in other sites, such as in the spinal cord and dorsal root ganglia (33) , may also contribute to this response. Recently, Audoly and co-workers (44) have reported ϳ50% reduction in the basal writhing reaction in mPGES-1-null mice. In that study, however, the peritoneal PGE 2 level in mPGES-1 KO mice during the basal writhing response was only modestly lower than that in WT mice (44) , as in our present study (Fig.  3D ). This indicates that other PGES enzymes may also participate in this immediate PGE 2 production and possibly pain perception. In this context, mPGES-2 and cPGES, both of which can be coupled with COX-1 (16 -18) , may be responsible for this residual PGE 2 production, a possibility that needs to be addressed in the future.
We found significant reduction in levels of peritoneal PGI 2 in mPGES-1 KO mice relative to WT mice under the LPS-primed condition. This finding suggests the existence of a pain amplification loop, in which mPGES-1-derived PGE 2 augments the production of PGI 2 , another pain modifier (24, 30) . Alternatively, assuming that macrophages are the main source of these prostanoids in the writing model, decreased macrophage number at inflamed sites in mPGES-1-deficient mice (see below) may account for the reduced PGI 2 levels in these mice. The reduction of PGI 2 in mPGES-1 KO mice was not observed in the study by Audoly and co-workers (44) . This discrepancy may be because they assessed only the basal pain response (but not LPS-primed pain hypersensitivity) or simply because distinct mouse strains (C57BL/6 ϫ 129/SvJ versus DBA/1) were used for analyses.
Subcutaneous implantation of a cotton thread into the dorsum of the mouse induces formation of granulation tissue associated with angiogenesis (25) . In this model, the process of inflammation depends on histamine, which is de novo synthe- FIG. 7 . Radiological and histological findings of WT and mPGES-1 KO joints by CAIA induction. A, histopathological examination of knee joint sections of arthritis-induced WT (left panels) and KO (right panels) mice on day 28, stained with hematoxylin and eosin (upper two panels) and toluidine blue (lower two panels) at low (upper panels; magnification, ϫ25) and high (lower panels; magnification ϫ100). B, decrease in BMD of the knee periarticular region of arthritic mice compared with control mice. BMD was measured by dual energy x-ray absorptiometry using a bone mineral analyzer. C, radiographs of forepaws (upper panels) and TRAP staining of the metacarpal bones (lower panels; magnification, ϫ200) in arthritis-induced WT and KO mice on day 28. Arrowheads indicate the regions where the TRAP staining and histomorphometric analysis were performed. sized by HDC induced in infiltrating macrophages, and VEGF, a factor essential for new blood vessel formation. Granulation and angiogenesis are impaired in HDC-deficient mice, in which induction of VEGF in the granulation tissues is also markedly reduced (25) . This model of inflammation also depends on prostanoids (45), a notion also supported by our present study showing an inhibitory effect of indomethacin (Fig. 4A) . In this study, we found that mPGES-1 deficiency results in ameliorated granulation, edema, and angiogenesis (Figs. 4 and 5) . The main cell type expressing mPGES-1 in the granulation tissues is ascribed to macrophages (Fig. 5) , in which HDC is also markedly induced (25) . Notably, mPGES-1-derived PGE 2 appears to be linked, at least in part, to the induction of HDC and VEGF because the expression levels of HDC and VEGF are significantly lower in mPGES-1 KO mice than in WT mice (Fig.  4F) . The reduced angiogenesis and VEGF expression in this model seems to be reminiscent of the events observed in tumor tissues of mice deficient in the PGE receptors EP2 (46) and EP3 (47) . Thus, our results indicate that mPGES-1-derived PGE 2 , in cooperation with histamine and VEGF, plays a critical role in the development of inflammatory granulation and angiogenesis, thus eventually contributing to tissue remodeling.
Pharmacological and genetic evidence supports a functional link of cPLA 2 ␣, COX-2, and PGE 2 with human rheumatoid arthritis and its mouse experimental model, CIA (36 -43) . COX-2 and mPGES-1 are highly expressed in synovial lining cells of joint tissues from patients with rheumatoid arthritis (16, 48) . Administration of COX-2-selective inhibitors markedly reduces the severity of disease (42, 43) , and mice deficient in cPLA 2 ␣ (49), COX-2 (but not COX-1) (36) and the PGE receptor EP4 (50) display significant reductions in both clinical and histological signs of CIA. We now show, using a CAIA model, that the arthritic symptoms are apparently mild in mPGES-1 KO mice compared with replicate WT mice, even though the reduction of the arthritis scores in KO mice is partial (Fig. 6) . Moreover, bone destruction and juxtaarticular bone loss in CAIA are less obvious in mPGES-1 KO mice than in replicate WT mice (Fig. 7) . These observations are compatible with our recent finding that mPGES-1 is induced by and mediates the effects of bone-resorptive stimuli in vitro (51) . Because mPGES-1 deficiency leads to only 50% reduction of PGE 2 level in the arthritic tissue (Fig. 6B) , the residual PGE 2 , which may result from coupling between COX-2 and other PGES(s) such as mPGES-2, may also contribute to this disease.
The inhibition of joint destruction by mPGES-1 deficiency may at least in part be secondary to the inhibition of inflammation of the joints because proinflammatory cytokines, such as tumor necrosis factor ␣, interleukin-1 and -6, and fibroblast growth factor-2, are known to stimulate the differentiation and activation of osteoclasts through the induction of RANKL (for receptor activator of NF-B ligand) in osteoblasts/stromal cells (52) (53) (54) (55) . PGE 2 , which is known to be induced by these cytokines, also facilitates RANKL expression (56 -58) . Furthermore, PGE 2 has a potency to stimulate osteoclast formation from precursors directly in the absence of osteoblasts/stromal cells (59, 60) . Hence, reduced PGE 2 production by mPGES-1 deficiency in the CAIA may cause the decrease in bone destruction in both direct and indirect pathways.
While this study was under way, Audoly and co-workers (44) demonstrated a more profound contribution of mPGES-1 to another mouse arthritis model, the CIA model, in which mPGES-1-deficient DBA mice developed no or little arthritis. Interestingly, the incidence of CIA was reduced markedly in mPGES-1 KO mice in the study by Audoly and co-workers (44), whereas in our experimental setting all mPGES-1 KO mice still developed CAIA. This discrepancy may again result from differences in the mouse strains and the methods of arthritis induction employed. The CIA model employed by Audoly and co-workers (44) requires a competent adaptive immune response to chicken type II collagen and demonstrates development of anti-collagen antibodies with subsequent induction of arthritic response. In comparison, the passive CAIA approach used in this study bypasses the requirement for lymphocytes and other proximal adaptive immune responses. Audoly and co-workers (44) demonstrated that lower antibody titers were detected in mPGES-1 KO mice compared with WT mice, even though antibody levels did not necessarily correlate with onset and severity of arthritis in disease animals. Analysis of the anti-collagen antibody formation in COX-2-deficient mice reveals a remarkable decrease in this humoral response (36) . This point is supported further by the observation that COX-2-deficient mice exhibit altered helper T cell development, a process reversed by PGE 2 (61) . It is therefore possible that the results found in the CIA model (44) could be influenced in part by inadequate proximal lymphocyte-mediated responses in addition to the synovial symptoms. Thus, the use of the CAIA approach in our study allows a confined synovium-focused analysis and clearly demonstrates the specific role of synovial mPGES-1 in synovial inflammation.
Another interesting phenotype of mPGES-1 KO mice is the decrease in macrophage numbers at inflamed sites. Thus, in the KO mice, fewer macrophages are recovered from the peritoneal cavity after thioglycollate treatment (Fig. 2F) and are found immunohistochemically in the cotton thread-induced granulation tissue (Fig. 5D ) than those in WT mice. Although this event might result simply from mitigated inflammation in mPGES-1 KO mice, which would influence subsequent recruitment of macrophages, an alternative explanation is that mPGES-1-derived PGE 2 may affect the differentiation and migration of macrophages in an as yet unidentified way. Because adhesion to the culture dishes and subsequent survival (at least by 48 h) of isolated macrophages during culture were similar between mPGES-1 KO and WT mice (data not shown), it is more likely that mPGES-1-derived PGE 2 could affect the recruitment of macrophages in tissue microenvironments. With regard to this, several recent studies have argued the potential contribution of COX-2 and PGE 2 to this process. COX-2 KO mice experience delayed hematologic recovery after 5-fluorouracil treatment, even though the basal hematopoiesis is normal (62) . PGE 2 directly stimulates the in vitro proliferation of burst-forming unit of granulocyte-macrophage progenitors from CD34 ϩ cells (63) and regulates the production of macrophage colony-stimulating factor by bone marrow stromal cells (64) . The anaphylatoxin C5a and the chemokine macrophage inflammatory protein-1␣ promote the recruitment of monocytes into the peritoneal cavity of mice and their subsequent differentiation into macrophages, and these events are mediated indirectly by PGE 2 (65) . Moreover, PGE 2 stimulates the expression of CCR7, a receptor for the chemokine macrophage inflammatory protein-3␤, on monocytes through the PGE receptors EP2 and EP4, a process required for proper homing of monocyte-derived dendritic cells to the lymph nodes (66) . Thus, our present data may reflect an unexplored role of mPGES-1-derived PGE 2 in the differentiation and migration of macrophages, although further studies will be necessary to clarify this critical issue in a sophisticated approach.
Taken together, it can be concluded that mPGES-1 is involved in various types of inflammation, including pain hyperalgesia, granulation associated with angiogenesis, and inflammatory arthritis accompanying bone destruction. It should be noted that the writhe and arthritis tests involve LPS stimulation, and the degree to which this Toll-like receptor 4 agonist influences the observed predominance of mPGES-1 in each situation has not been defined. Therefore, the generalization of the present finding to a variety of non-LPS influenced inflammatory responses (except the granulation response, which is assessed here) will need further elucidation. Irrespective of this argument, accumulating evidence suggests that mPGES-1 is also involved in tumorigenesis (12, 67) , delayed skin hypersensitivity (44) , and fever (68) . These facts, together with its inducible property during inflammation and other pathogenesis (4 -6), agree well with the proposal that mPGES-1 represents a target for the treatment of various inflammatory diseases that will spare important physiological systems in which other PGs are involved (44) . However, implementation of this concept will still require caution, because besides its proinflammatory functions PGE 2 exerts homeostatic and antiinflammatory effects in several organs, such as the gastrointestinal tract (69, 70) , lung (71) , and kidney (72) . It also remains to be elucidated whether other PGES enzymes exhibit redundant or specific functions in particular situations in vivo. The absence of gross abnormalities in ductus arteriosus closure immediately after birth, which is markedly impaired in COX-1/COX-2-double (73) and EP4 (74) KO mice, and in female reproduction, where EP2 is involved in the ovulation step (75) , implies the compensatory participation of other PGESs in these physiological events.
